Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results

Authors: Gerd Gran, Jörg Aßmus, Anne Ma Dyrhol-Riise

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

Tuberculosis (TB) presents globally a significant health problem and health care workers (HCW) are at increased risk of contracting TB infection. There is no diagnostic gold standard for latent TB infection (LTBI), but both blood based interferon-gamma release assays (IGRA) and the tuberculin skin test (TST) are used. According to the national guidelines, HCW who have been exposed for TB should be screened and offered preventive anti-TB chemotherapy, but the role of IGRA in HCW screening is still unclear.

Methods

A total of 387 HCW working in clinical and laboratory departments in three major hospitals in the Western region of Norway with possible exposure to TB were included in a cross-sectional study. The HCW were asked for risk factors for TB and tested with TST and the QuantiFERON®TB Gold In-Tube test (QFT). A logistic regression model analyzed the associations between risk factors for TB and positive QFT or TST.

Results

A total of 13 (3.4%) demonstrated a persistent positive QFT, whereas 214 (55.3%) had a positive TST (≥ 6 mm) and 53 (13.7%) a TST ≥ 15 mm. Only ten (4.7%) of the HCW with a positive TST were QFT positive. Origin from a TB-endemic country was the only risk factor associated with a positive QFT (OR 14.13, 95% CI 1.37 - 145.38, p = 0.026), whereas there was no significant association between risk factors for TB and TST ≥ 15 mm. The five HCW with an initial positive QFT that retested negative all had low interferon-gamma (IFN-γ) responses below 0.70 IU/ml when first tested.

Conclusions

We demonstrate a low prevalence of LTBI in HCW working in hospitals with TB patients in our region. The “IGRA-only” seems like a desirable screening strategy despite its limitations in serial testing, due to the high numbers of discordant TST positive/IGRA negative results in HCW, probably caused by BCG vaccination or boosting due to repetitive TST testing. Thus, guidelines for TB screening in HCW should be updated in order to secure accurate diagnosis of LTBI and offer proper treatment and follow-up.
Appendix
Available only for authorised users
Literature
1.
go back to reference Joshi R, Reingold AL, Menzies D, Pai M: Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med. 2006, 3 (12): e494-10.1371/journal.pmed.0030494.CrossRefPubMedPubMedCentral Joshi R, Reingold AL, Menzies D, Pai M: Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med. 2006, 3 (12): e494-10.1371/journal.pmed.0030494.CrossRefPubMedPubMedCentral
2.
go back to reference Menzies D, Joshi R, Pai M: Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis. 2007, 11: 593e605- Menzies D, Joshi R, Pai M: Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis. 2007, 11: 593e605-
5.
go back to reference Menzies D: What does tuberculin reactivity after bacille Calmette- Guerin vaccination tell us?. Clin Infect Dis. 2000, 31 (Suppl 3): S71-S74.CrossRefPubMed Menzies D: What does tuberculin reactivity after bacille Calmette- Guerin vaccination tell us?. Clin Infect Dis. 2000, 31 (Suppl 3): S71-S74.CrossRefPubMed
6.
go back to reference Nahid P, Pai M, Hopewell PC: Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc. 2006, 3 (1): 103-110. 10.1513/pats.200511-119JH.CrossRefPubMedPubMedCentral Nahid P, Pai M, Hopewell PC: Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc. 2006, 3 (1): 103-110. 10.1513/pats.200511-119JH.CrossRefPubMedPubMedCentral
7.
go back to reference Pai M, Kalantri S, Dheda K: New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn. 2006, 3: 413-422.CrossRef Pai M, Kalantri S, Dheda K: New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn. 2006, 3: 413-422.CrossRef
8.
go back to reference Andersen P, Munk ME, Pollock JM, Doherty TM: Specific immune-based diagnosis of tuberculosis. Lancet. 2000, 356 (9235): 1099-1104. 10.1016/S0140-6736(00)02742-2.CrossRefPubMed Andersen P, Munk ME, Pollock JM, Doherty TM: Specific immune-based diagnosis of tuberculosis. Lancet. 2000, 356 (9235): 1099-1104. 10.1016/S0140-6736(00)02742-2.CrossRefPubMed
9.
go back to reference Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D: Interferon-c release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011, 37: 88-99. 10.1183/09031936.00115110.CrossRefPubMed Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D: Interferon-c release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011, 37: 88-99. 10.1183/09031936.00115110.CrossRefPubMed
10.
go back to reference European Centre for Disease Prevention and Control: Use of interferon-gamma release assays in support of TB diagnosis. 2011, Stockholm: ECDC European Centre for Disease Prevention and Control: Use of interferon-gamma release assays in support of TB diagnosis. 2011, Stockholm: ECDC
11.
go back to reference Jensen PA, Lambert LA, Iademarco MF, Ridzon R, CDC: Guidelines for preventing the transmission of mycobacterium tuberculosis in health care settings, 2005. MMWR Recomm Rep. 2005, 54: 1-141.PubMed Jensen PA, Lambert LA, Iademarco MF, Ridzon R, CDC: Guidelines for preventing the transmission of mycobacterium tuberculosis in health care settings, 2005. MMWR Recomm Rep. 2005, 54: 1-141.PubMed
12.
go back to reference Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control: National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK). 2011, London: National Institute for Health and Clinical Excellence (UK) Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control: National Collaborating Centre for Chronic Conditions (UK), Centre for Clinical Practice at NICE (UK). 2011, London: National Institute for Health and Clinical Excellence (UK)
13.
go back to reference Menzies D, Pai M, Comstock G: Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007, 146 (5): 340-354. 10.7326/0003-4819-146-5-200703060-00006.CrossRefPubMed Menzies D, Pai M, Comstock G: Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007, 146 (5): 340-354. 10.7326/0003-4819-146-5-200703060-00006.CrossRefPubMed
14.
go back to reference Winje B, Oftung F, Mannsåker T, Dyrhol-Riise AM: New immunological blood based assays for detection of tuberculosis. A report from the Infectious Disease Control Register (Norwegian). MSIS-rapport. 2007, 35: 10- Winje B, Oftung F, Mannsåker T, Dyrhol-Riise AM: New immunological blood based assays for detection of tuberculosis. A report from the Infectious Disease Control Register (Norwegian). MSIS-rapport. 2007, 35: 10-
15.
go back to reference Nienhaus A, Loddenkemper R, Hauer B, Wolf N, Diel R: Latent tuberculosis infection in healthcare workers-evaluation of an Interferon-gamma release assay. Pneumology. 2007, 61 (4): 219-223. 10.1055/s-2007-959161.CrossRef Nienhaus A, Loddenkemper R, Hauer B, Wolf N, Diel R: Latent tuberculosis infection in healthcare workers-evaluation of an Interferon-gamma release assay. Pneumology. 2007, 61 (4): 219-223. 10.1055/s-2007-959161.CrossRef
16.
go back to reference Soborg B, Andersen AB, Larsen HK, Weldingh K, Andersen P, Kofoed K, Ravn P: Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Scand J Infect Dis. 2007, 39 (6–7): 554-559.CrossRefPubMed Soborg B, Andersen AB, Larsen HK, Weldingh K, Andersen P, Kofoed K, Ravn P: Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Scand J Infect Dis. 2007, 39 (6–7): 554-559.CrossRefPubMed
17.
go back to reference Drobniewski F, Balabanova Y, Zakamova E, Nikolayevskyy V, Fedorin I: Rates of latent tuberculosis in health care staff in Russia. PLoS Med. 2007, 4 (2): e55-10.1371/journal.pmed.0040055.CrossRefPubMedPubMedCentral Drobniewski F, Balabanova Y, Zakamova E, Nikolayevskyy V, Fedorin I: Rates of latent tuberculosis in health care staff in Russia. PLoS Med. 2007, 4 (2): e55-10.1371/journal.pmed.0040055.CrossRefPubMedPubMedCentral
18.
go back to reference Vinton P, Mihrshahi S, Johnson P, Jenkin GA, Jolley D, Biggs BA: Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol. 2009, 3: 215-221.CrossRef Vinton P, Mihrshahi S, Johnson P, Jenkin GA, Jolley D, Biggs BA: Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol. 2009, 3: 215-221.CrossRef
19.
go back to reference Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T: Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol. 2006, 27 (5): 442-448. 10.1086/504358.CrossRefPubMed Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T: Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol. 2006, 27 (5): 442-448. 10.1086/504358.CrossRefPubMed
20.
go back to reference Stebler A, Iseli P, Muhlemann K, Bodmer T: Whole-blood interferon- gamma release assay for baseline tuberculosis screening of healthcare workers at a swiss university hospital. Infect Control Hosp Epidemiol. 2008, 29 (7): 681-683. 10.1086/588587.CrossRefPubMed Stebler A, Iseli P, Muhlemann K, Bodmer T: Whole-blood interferon- gamma release assay for baseline tuberculosis screening of healthcare workers at a swiss university hospital. Infect Control Hosp Epidemiol. 2008, 29 (7): 681-683. 10.1086/588587.CrossRefPubMed
21.
go back to reference Ringshausen FC, Schlosser S, Nienhaus A, Schablon A, Schultze- Werninghaus G, Rohde G: In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis. J Occup Med Toxicol. 2009, 4: 11-10.1186/1745-6673-4-11.CrossRefPubMedPubMedCentral Ringshausen FC, Schlosser S, Nienhaus A, Schablon A, Schultze- Werninghaus G, Rohde G: In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis. J Occup Med Toxicol. 2009, 4: 11-10.1186/1745-6673-4-11.CrossRefPubMedPubMedCentral
22.
go back to reference Schablon A, Beckmann G, Harling M, Diel R, Nienhaus A: Prevalence of Latent Tuberculosis Infection among Health Care Workers in a hospital for pulmonary diseases. J Occup Med Toxicol. 2009, 4: 1-10.1186/1745-6673-4-1.CrossRefPubMedPubMedCentral Schablon A, Beckmann G, Harling M, Diel R, Nienhaus A: Prevalence of Latent Tuberculosis Infection among Health Care Workers in a hospital for pulmonary diseases. J Occup Med Toxicol. 2009, 4: 1-10.1186/1745-6673-4-1.CrossRefPubMedPubMedCentral
23.
go back to reference Storla DG, Kristiansen I, Oftung F, Korsvold GE, Gaupset M, Gran G, Øverby AK, Dyrhol-Riise AM, Bjune GA: Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposure. BMC Infect Dis. 2009, 9: 60-10.1186/1471-2334-9-60.CrossRefPubMedPubMedCentral Storla DG, Kristiansen I, Oftung F, Korsvold GE, Gaupset M, Gran G, Øverby AK, Dyrhol-Riise AM, Bjune GA: Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposure. BMC Infect Dis. 2009, 9: 60-10.1186/1471-2334-9-60.CrossRefPubMedPubMedCentral
24.
go back to reference Nienhaus A, Schablon A, Siano B, le Bacle C, Diel R: Evaluation of the Interferon-gamma Release Assay in Healthcare Workers. Int Arch Occup Environ Health. 2008, 81 (3): 295-300.CrossRefPubMed Nienhaus A, Schablon A, Siano B, le Bacle C, Diel R: Evaluation of the Interferon-gamma Release Assay in Healthcare Workers. Int Arch Occup Environ Health. 2008, 81 (3): 295-300.CrossRefPubMed
25.
go back to reference Schablon A, Harling M, Diel R, Nienhaus A: Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study. BMC Infect Dis. 2010, 10: 107-10.1186/1471-2334-10-107.CrossRefPubMedPubMedCentral Schablon A, Harling M, Diel R, Nienhaus A: Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study. BMC Infect Dis. 2010, 10: 107-10.1186/1471-2334-10-107.CrossRefPubMedPubMedCentral
26.
go back to reference Nienhaus A, Schablon A, Tripodi D, Torres Costa J: The prevalence of latent tuberculosis infections among health-care workers–a three-country comparison. Pneumologie. 2011, 12: 726-729. Nienhaus A, Schablon A, Tripodi D, Torres Costa J: The prevalence of latent tuberculosis infections among health-care workers–a three-country comparison. Pneumologie. 2011, 12: 726-729.
27.
go back to reference Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Fujii M, Oka M: Usefulness of QuantiFERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers. Intern Med. 2007, 46: 1543-1549. 10.2169/internalmedicine.46.0088.CrossRefPubMed Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Fujii M, Oka M: Usefulness of QuantiFERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers. Intern Med. 2007, 46: 1543-1549. 10.2169/internalmedicine.46.0088.CrossRefPubMed
28.
go back to reference Lee SS, Liu YC, Huang TS, Chen YS, Tsai HC, Wann SR, Lin HH: Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. Scand J Infect Dis. 2008, 40 (5): 373-380. 10.1080/00365540701730743.CrossRefPubMed Lee SS, Liu YC, Huang TS, Chen YS, Tsai HC, Wann SR, Lin HH: Comparison of the interferon- gamma release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. Scand J Infect Dis. 2008, 40 (5): 373-380. 10.1080/00365540701730743.CrossRefPubMed
29.
go back to reference Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M: Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax. 2012, 67 (1): 62-70. 10.1136/thx.2010.143180.CrossRefPubMed Zwerling A, van den Hof S, Scholten J, Cobelens F, Menzies D, Pai M: Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax. 2012, 67 (1): 62-70. 10.1136/thx.2010.143180.CrossRefPubMed
30.
go back to reference Winje BA, Oftung F, Korsvold GE, Mannsåker T, Jeppesen AS, Harstad I, Heier BT, Heldal E: Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test. BMC Infect Dis. 2008, 8: 65-10.1186/1471-2334-8-65.CrossRefPubMedPubMedCentral Winje BA, Oftung F, Korsvold GE, Mannsåker T, Jeppesen AS, Harstad I, Heier BT, Heldal E: Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test. BMC Infect Dis. 2008, 8: 65-10.1186/1471-2334-8-65.CrossRefPubMedPubMedCentral
31.
go back to reference Winje BA, Oftung F, Korsvold GE, Mannsåker T, Nesthus IL, Harstad I, Dyrhol-Riise AM, Heldal E: School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay. BMC Infect Diseases. 2008, 8: 140-10.1186/1471-2334-8-140.CrossRef Winje BA, Oftung F, Korsvold GE, Mannsåker T, Nesthus IL, Harstad I, Dyrhol-Riise AM, Heldal E: School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay. BMC Infect Diseases. 2008, 8: 140-10.1186/1471-2334-8-140.CrossRef
32.
go back to reference Dyrhol-Riise AM, Gran G, Wenzel-Larsen T, Blomberg B, Gill HC, Mørkve O: Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-Tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis. 2010, 10: 57-10.1186/1471-2334-10-57.CrossRefPubMedPubMedCentral Dyrhol-Riise AM, Gran G, Wenzel-Larsen T, Blomberg B, Gill HC, Mørkve O: Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-Tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis. 2010, 10: 57-10.1186/1471-2334-10-57.CrossRefPubMedPubMedCentral
33.
go back to reference Harstad I, Winje BA, Heldal E, Oftung F, Jacobsen GW: Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers. Int J Tuberc Lung Dis. 2010, 9: 1209-1211. Harstad I, Winje BA, Heldal E, Oftung F, Jacobsen GW: Predictive values of QuantiFERON-TB Gold testing in screening for tuberculosis disease in asylum seekers. Int J Tuberc Lung Dis. 2010, 9: 1209-1211.
34.
go back to reference Nasjonalt Folkehelseinstitutt. Veiledning om vaksinasjon for helsepersonell (Norwegian): Guidelines for vaccination of health care workers. 2008, Oslo: Nasjonalt Folkehelseinstitutt Nasjonalt Folkehelseinstitutt. Veiledning om vaksinasjon for helsepersonell (Norwegian): Guidelines for vaccination of health care workers. 2008, Oslo: Nasjonalt Folkehelseinstitutt
35.
go back to reference Zwerling A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Benedetti A, Dendukuri N, Menzies D, Pai M: TB Screening in Canadian Health Care Workers Using Interferon-Gamma Release Assays. PLoS One. 2012, 7 (8): e43014-10.1371/journal.pone.0043014.CrossRefPubMedPubMedCentral Zwerling A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Benedetti A, Dendukuri N, Menzies D, Pai M: TB Screening in Canadian Health Care Workers Using Interferon-Gamma Release Assays. PLoS One. 2012, 7 (8): e43014-10.1371/journal.pone.0043014.CrossRefPubMedPubMedCentral
36.
go back to reference Ringshausen FC, Schablon A, Nienhaus A: Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review. J Occup Med Toxicol. 2012, 7 (1): 6-10.1186/1745-6673-7-6.CrossRefPubMedPubMedCentral Ringshausen FC, Schablon A, Nienhaus A: Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review. J Occup Med Toxicol. 2012, 7 (1): 6-10.1186/1745-6673-7-6.CrossRefPubMedPubMedCentral
37.
go back to reference Fong KS, Tomford JW, Teixeira L, Fraser TG, van Duin D, Yen-Lieberman B, Gordon SM, Miranda C: Challenges of interferon-γ release assay conversions in serial testing of health-care workers in a TB control program. Chest. 2012, 142 (1): 55-62. 10.1378/chest.11-0992.CrossRefPubMed Fong KS, Tomford JW, Teixeira L, Fraser TG, van Duin D, Yen-Lieberman B, Gordon SM, Miranda C: Challenges of interferon-γ release assay conversions in serial testing of health-care workers in a TB control program. Chest. 2012, 142 (1): 55-62. 10.1378/chest.11-0992.CrossRefPubMed
38.
go back to reference Park JS, Lee JS, Kim MY, Lee CH, Yoon HI, Lee SM, Yoo CG, Kim YW, Han SK, Yim JJ: Monthly follow-ups of interferon-γ release assays among healthcare workers in contact with patients with TB. Chest. 2012, 142 (6): 461-468. Park JS, Lee JS, Kim MY, Lee CH, Yoon HI, Lee SM, Yoo CG, Kim YW, Han SK, Yim JJ: Monthly follow-ups of interferon-γ release assays among healthcare workers in contact with patients with TB. Chest. 2012, 142 (6): 461-468.
39.
go back to reference Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K: IGRA Expert Committee; Centers for Disease Control and Prevention (CDC) Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States. MMWR Recomm Rep. 2010, 59 (RR-5): 1-25.PubMed Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K: IGRA Expert Committee; Centers for Disease Control and Prevention (CDC) Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States. MMWR Recomm Rep. 2010, 59 (RR-5): 1-25.PubMed
40.
go back to reference Nienhaus A, Schablon A, Costa JT, Diel R: Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Heal Serv Res. 2011, 11: 247-10.1186/1472-6963-11-247.CrossRef Nienhaus A, Schablon A, Costa JT, Diel R: Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Heal Serv Res. 2011, 11: 247-10.1186/1472-6963-11-247.CrossRef
41.
go back to reference Wrighton-Smith P, Sneed L, Humphrey F, Tao X, Bernacki E: Screening health care workers with interferon-γ release assay versus tuberculin skin test: impact on costs and adherence to testing (the SWITCH study). J Occup Environ Med. 2012, 54 (7): 806-815. 10.1097/JOM.0b013e318254620f.CrossRefPubMed Wrighton-Smith P, Sneed L, Humphrey F, Tao X, Bernacki E: Screening health care workers with interferon-γ release assay versus tuberculin skin test: impact on costs and adherence to testing (the SWITCH study). J Occup Environ Med. 2012, 54 (7): 806-815. 10.1097/JOM.0b013e318254620f.CrossRefPubMed
Metadata
Title
Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results
Authors
Gerd Gran
Jörg Aßmus
Anne Ma Dyrhol-Riise
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-353

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue